Jasper Therapeutics (JSPR) Prepaid Assets (2019 - 2025)
Jasper Therapeutics (JSPR) posted quarterly Prepaid Assets of $664000.0 for Q4 2025, down 15.31% year-over-year from $784000.0 in Q4 2024, and down 23.06% quarter-over-quarter from $863000.0 in Q3 2025.
Jasper Therapeutics (JSPR) Prepaid Assets (2019 - 2025) Analysis & Trends
Jasper Therapeutics' Prepaid Assets history runs 7 years deep, the most recent figure standing at $664000.0 for Q4 2025.
- In Q4 2025, Prepaid Assets fell 15.31% year-over-year to $664000.0; the TTM figure through Dec 2025 stood at $664000.0 (down 15.31% YoY), while the FY2025 annual figure was $664000.0, down 15.31% from the prior year.
- Prepaid Assets for Q4 2025 stood at $664000.0, down from $863000.0 in the prior quarter.
- The five-year high for Prepaid Assets was $3.5 million in Q2 2025, with the low at $10000.0 in Q3 2021.
- The 5-year median for Prepaid Assets is $819000.0 (2024), against an average of $1.4 million.
- The sharpest annual moves came in 2022 and 2024: Prepaid Assets surged 14510.0% in 2022, then plunged 96.55% in 2024.
- Jasper Therapeutics' Prepaid Assets stood at $3.1 million in 2021, then fell by 9.97% to $2.8 million in 2022, then declined by 27.22% to $2.1 million in 2023, then slumped by 61.77% to $784000.0 in 2024, then slipped by 15.31% to $664000.0 in 2025.
- Business Quant data shows JSPR's Prepaid Assets at $664000.0 in Q4 2025, $863000.0 in Q3 2025, and $3.5 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.81 Bn | 130.96 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.07 Bn | 78.08 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.47 Bn | 60.29 Bn | 1.37 Bn |
| 4 | Moderna | 55.64 Bn | 50.50 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.99 Bn | 36.89 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.68 Bn | 28.37 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.69 Bn | 9.29 Bn | 668.28 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - |
| 10 | Jasper Therapeutics | 20.09 Mn | 20.09 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 664,000.00 |
| Sep 30, 2025 | 863,000.00 |
| Jun 30, 2025 | 3.46 Mn |
| Mar 31, 2025 | 854,000.00 |
| Dec 31, 2024 | 784,000.00 |
| Sep 30, 2024 | 625,000.00 |
| Jun 30, 2024 | 95,000.00 |
| Mar 31, 2024 | 440,000.00 |
| Dec 31, 2023 | 2.05 Mn |
| Sep 30, 2023 | 411,000.00 |
| Jun 30, 2023 | 2.76 Mn |
| Mar 31, 2023 | 721,000.00 |
| Dec 31, 2022 | 2.82 Mn |
| Sep 30, 2022 | 1.46 Mn |
| Jun 30, 2022 | 2.47 Mn |
| Mar 31, 2022 | 3.40 Mn |
| Dec 31, 2021 | 3.13 Mn |
| Sep 30, 2021 | 10,000.00 |
| Jun 30, 2021 | 103,577.00 |
| Mar 31, 2021 | 161,645.00 |